Varda Space Industries has signed its first major agreement with a pharmaceutical company to develop improved drugs in microgravity.
Varda announced May 13 an agreement with United Therapeutics to study development of novel formulations of drugs, starting with treatments for rare pulmonary disease, on Varda's spacecraft.
"Microgravity gives us a fundamentally different environment to manufacture pharmaceuticals that are otherwise impossible on Earth," said Will Bruey, chief executive of Varda, in a statement.
